Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$10M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$181M |
Are Alaunos Therapeutics Insiders Buying or Selling?
Alaunos Therapeutics (TCRT) has had no reported insider transactions in the past 90 days. The most recent was Jaime Vieser, who bought 250 shares at $4.49 on June 24, 2025.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the TCRT AI Score. For government officials trading this stock, see TCRT congressional trading.
Who’s Trading Alaunos Therapeutics Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Jaime Vieser | Sold $6,000 | 3 | Jun 24, 2025 |
| Robert Postma | Bought $5,500 | 3 | Jun 24, 2025 |
Recent Alaunos Therapeutics Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jaime Vieser | Jun 24, 2025 | Buy | 250 | $4.49 | $1,100 |
| Robert Postma | Jun 24, 2025 | Buy | 600 | $4.49 | $2,700 |
| Robert Postma | Apr 11, 2025 | Buy | 500 | $2.76 | $1,400 |
| Robert Postma | Apr 11, 2025 | Buy | 500 | $2.76 | $1,400 |
| Jaime Vieser | Dec 31, 2024 | Sell | 2,182 | $2.01 | $4,400 |
| Jaime Vieser | Dec 31, 2024 | Sell | 818 | $2 | $1,600 |
Frequently Asked Questions: Alaunos Therapeutics Insider Trading
Alaunos Therapeutics insiders have not reported any transactions in the past 90 days.
The most recent sale was by Jaime Vieser who sold 2,182 shares on December 31, 2024. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Postma Robert W has bought the most TCRT stock in the last 2 years, with a total value of $5,500.
Vieser Jaime has sold the most TCRT stock in the last 2 years, with a total value of $6,000.
According to our estimates, the total value of insider transactions for Alaunos Therapeutics in the last 2 years is positive, amounting to $550. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
